TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1111465

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Combination therapy (intermittent melphalan and prednisone)
Number of subjects: 22
Study: 30257665

Group type: EXPERIMENTAL
Intervention: eLearning MHFA course
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: blended MHFA course
Number of subjects: 608

Group type: COMPARATOR
Intervention: Red Cross eLearning Provide First Aid (PFA)
Number of subjects: 608
Study: 27462608

Group type: EXPERIMENTAL
Intervention: BodyPump group training (A)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Individual follow‐up by a personal trainer (B)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Nonsupervised exercise (C)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (D)
Number of subjects: 143
Study: 25046944

Group type: EXPERIMENTAL
Intervention: Yigan Fupi Decoction (YFD)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Pinaverium Bromide Tablet
Number of subjects: 116
Study: 22833021

Group type: EXPERIMENTAL
Intervention: Small-caliber colonoscope
Number of subjects: 330

Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 330
Study: 19704158

Group type: EXPERIMENTAL
Intervention: CPT + CPT
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: CPT + FST
Number of subjects: 102

Group type: COMPARATOR
Intervention: CPT
Number of subjects: 102
Study: 17891683

Group type: COMPARATOR
Intervention: 14C-xylose breath test
Number of subjects: 101

Group type: COMPARATOR
Intervention: 13C-xylose breath test
Number of subjects: 101

Group type: COMPARATOR
Intervention: Gas fraction index (30 min/210 min)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Gas fraction index after gluten-free diet
Number of subjects: 101
Study: 15661459

Group type: EXPERIMENTAL
Intervention: Nefopam 80 mg continuous infusion
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nefopam 120 mg continuous infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo continuous infusion
Number of subjects: 60
Study: 12878920

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg daily) + Cognitive Behavioral Therapy (CBT)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg daily) + Supportive Therapy
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo + Cognitive Behavioral Therapy (CBT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo + Supportive Therapy
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg daily)
Number of subjects: 118
Study: 9988404

Group type: EXPERIMENTAL
Intervention: Cabergoline (0.5 mg orally every week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (orally every week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 30
Study: 7487796

Group type: EXPERIMENTAL
Intervention: 75-200 mg dosage range of tricyclic antidepressant
Number of subjects: 0

Group type: COMPARATOR
Intervention: 75-425 mg dosage range of tricyclic antidepressant
Number of subjects: 0
Study: 2323695

Group type: COMPARATOR
Intervention: Hand-held applanation tonometer (HAT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Mackay‐Marg tonometer
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: NCT A
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: NCT B
Number of subjects: 99
Study: 388987

Group type: EXPERIMENTAL
Intervention: Vivalan (viloxazine hydrochloride)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 28
Study: 31714584

Group type: EXPERIMENTAL
Intervention: Arsenic trioxide (ATO) plus all‐trans retinoic acid (ATRA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: ATRA plus chemotherapy (CT)
Number of subjects: 0
Study: 29344773

Group type: EXPERIMENTAL
Intervention: Hybrid intervention (combination of online sexual health program and supplemental class lessons)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Online videos for training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid intervention
Number of subjects: 0
Study: 26294364

Group type: EXPERIMENTAL
Intervention: Sedentary condition (free-living sedentary time increased by an average of 32 min/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control condition (usual activity)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Sedentary condition
Number of subjects: 43
Study: 24131664

Group type: EXPERIMENTAL
Intervention: Epidural oxycodone (0.1 mg kg(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Intravenous oxycodone (0.1 mg kg(‐1))
Number of subjects: 24
Study: 22735432

Group type: EXPERIMENTAL
Intervention: Low-fat diet (60% of energy from carbohydrate, 20% from fat, 20% from protein; high glycemic load)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet (40% from carbohydrate, 40% from fat, and 20% from protein; moderate glycemic load)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate diet (10% from carbohydrate, 60% from fat, and 30% from protein; low glycemic load)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low-glycemic index diet
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate diet
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Hormone levels and metabolic syndrome components
Number of subjects: 21
Study: 20089960

Group type: EXPERIMENTAL
Intervention: Cladribine 3.5 mg/kg
Number of subjects: 1326

Group type: EXPERIMENTAL
Intervention: Cladribine 5.25 mg/kg
Number of subjects: 1326

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1326
Study: 16089141

Group type: EXPERIMENTAL
Intervention: Shenqi fuzheng injection (SFI)
Number of subjects: 85

Group type: COMPARATOR
Intervention: No Shenqi fuzheng injection (SFI)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Radical operation
Number of subjects: 85
Study: 12074185

Group type: EXPERIMENTAL
Intervention: Kiwifruit (1 kiwifruit per 30 kg bodyweight)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Normal diet without kiwifruit
Number of subjects: 38
Study: 10480824

Group type: EXPERIMENTAL
Intervention: Multifaceted shared care intervention including multidisciplinary consultation, training of general practitioners and carers, and health education
Number of subjects: 220

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 220
Study: 7552187

Group type: EXPERIMENTAL
Intervention: Deflazacort
Number of subjects: 30

Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 30
Study: 1682327

Group type: EXPERIMENTAL
Intervention: Benadryl (Parke‐Davis, Morris Plains N.J.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Atarax (Roerig Div. of Pfizer Inc., New York, N.Y.)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Polyhist Forte (Mikart Inc., Atlanta, Ga.)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 100
Study: 7028798

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30849057

Group type: EXPERIMENTAL
Intervention: Enhanced Program for Early Psychosis (ePEP)
Number of subjects: 0
Study: 28818417

Group type: EXPERIMENTAL
Intervention: Five face‐to‐face counseling sessions by an exercise specialist
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: One face‐to‐face counseling session followed by four telephone calls by an exercise specialist
Number of subjects: 203

Group type: COMPARATOR
Intervention: Generic mailed physical activity brochure (usual care)
Number of subjects: 203
Study: 26471584

Group type: EXPERIMENTAL
Intervention: Malted wheat (MLT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Whole-grain wheat (CON)
Number of subjects: 10
Study: 25153776

Group type: EXPERIMENTAL
Intervention: transcranial oscillating direct current stimulation (toDCS) at 0.75 Hz
Number of subjects: 12

Group type: COMPARATOR
Intervention: sham condition
Number of subjects: 12
Study: 22568921

Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg IV or orally every 12 h
Number of subjects: 477

Group type: COMPARATOR
Intervention: Vancomycin 15 mg/kg or 1 g IV every 12 h
Number of subjects: 477

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 477

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 477
Study: 19293413

Group type: EXPERIMENTAL
Intervention: Pactimibe 100 mg/d
Number of subjects: 892

Group type: EXPERIMENTAL
Intervention: Pactimibe
Number of subjects: 892

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 892
Study: 17260529

Group type: EXPERIMENTAL
Intervention: Suboptimal vitamin B6 status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elevated homocysteine concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other mechanisms independent of homocysteine
Number of subjects: 0
Study: 16365466

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 101

Group type: COMPARATOR
Intervention: Self-care book
Number of subjects: 101

Group type: COMPARATOR
Intervention: Conventional therapeutic exercise
Number of subjects: 101
Study: 12507242

Group type: EXPERIMENTAL
Intervention: 3i threaded implants (self-tapping, ICE, Osseotite)
Number of subjects: 528
Study: 9842837

Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Domperidone 20 mg
Number of subjects: 100
Study: 8445432

Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate (10 mg) twice weekly
Number of subjects: 59

Group type: COMPARATOR
Intervention: Thiotepa (10 mg) twice weekly
Number of subjects: 59
Study: 3731893

Group type: EXPERIMENTAL
Intervention: Pursed lips breathing (PLB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: General relaxation (Rlx)
Number of subjects: 12
Study: 30346225

Group type: EXPERIMENTAL
Intervention: Energy-dense enteral nutrition (1.5 kcal/ml)
Number of subjects: 3957

Group type: COMPARATOR
Intervention: Routine enteral nutrition (1.0 kcal/ml)
Number of subjects: 3957
Study: 27060053

Group type: EXPERIMENTAL
Intervention: Phosphodiesterase type 5 inhibitor
Number of subjects: 0
Study: 24799001

Group type: EXPERIMENTAL
Intervention: Maternal depressive symptoms
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Higher involvement expectancies
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Poorer youth adherence
Number of subjects: 225
Study: 23189136

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (15 mins/1 mA)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (15 mins/1 mA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation (15 mins/1 mA)
Number of subjects: 15
Study: 21198247

Group type: EXPERIMENTAL
Intervention: Client feedback condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 0
Study: 16701078

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) for 3 months
Number of subjects: 117

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 117
Study: 15766833

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 3817

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 3817
Study: 11888460

Group type: EXPERIMENTAL
Intervention: Polymeric sealant (CoSeal)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Gelfoam/thrombin
Number of subjects: 148
Study: 10223535

Group type: EXPERIMENTAL
Intervention: Arthroscopic technique including a capsular plication
Number of subjects: 41

Group type: COMPARATOR
Intervention: Open procedure with Mitec anchors
Number of subjects: 41
Study: 7542973

Group type: EXPERIMENTAL
Intervention: Ultraline fiber
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Urolase fiber
Number of subjects: 93
Study: 2039173

Group type: EXPERIMENTAL
Intervention: BSS Plus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactated Ringer's with dextrose and bicarbonate
Number of subjects: 0
Study: 6939009

Group type: EXPERIMENTAL
Intervention: d-amphetamine
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: l-amphetamine
Number of subjects: 27

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 27
Study: 31642718

Group type: EXPERIMENTAL
Intervention: Prophylactic endoscopic closure after colorectal ESD
Number of subjects: 220

Group type: COMPARATOR
Intervention: No prophylactic endoscopic closure after colorectal ESD
Number of subjects: 220
Study: 28775307

Group type: EXPERIMENTAL
Intervention: Preferential attachment (PA) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shocks of differing length and severity (attacks and errors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-term shocks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated attacks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attacks vs. errors
Number of subjects: 0
Study: 25880068

Group type: EXPERIMENTAL
Intervention: Indapamide sustained release 1.5 mg ± perindopril 2 to 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study: 24091772

Group type: EXPERIMENTAL
Intervention: Fittslog condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sinelog condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fitts condition
Number of subjects: 0
Study: 21927686

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at the rate of 0.17 µg/kg/min
Number of subjects: 80

Group type: COMPARATOR
Intervention: N(2)O (70%)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Remifentanil infusion
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 80
Study: 19728002

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular block
Number of subjects: 103

Group type: COMPARATOR
Intervention: Dual motor endpoint nerve stimulation infraclavicular block
Number of subjects: 103
Study: 17767023

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0
Study: 15531676

Group type: COMPARATOR
Intervention: Ferrous sulfate (FS)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate and zinc sulfate (FSZn)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Ferrous sulfate, zinc sulfate, and vitamin A (FSZnA)
Number of subjects: 323
Study: 11433856

Group type: EXPERIMENTAL
Intervention: Occlusal appliances
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonoccluding appliances
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 9771209

Group type: EXPERIMENTAL
Intervention: MRI of the wrist
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: HLA‐DRB1*04 or *01 (shared epitope +ve)
Number of subjects: 42
Study: 7793548

Group type: EXPERIMENTAL
Intervention: Epidural infusion of bupivacaine 0.125% with diamorphine 0.0025%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Epidural infusion of bupivacaine 0.062% with diamorphine 0.0025%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Epidural infusion of bupivacaine 0.031% with diamorphine 0.0025%
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: All bupivacaine infusions
Number of subjects: 63
Study: 2569488

Group type: EXPERIMENTAL
Intervention: Metronidazole (0.6 g/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sulfasalazine (2 g/day)
Number of subjects: 40
Study: 798195

Group type: EXPERIMENTAL
Intervention: gemfibrozil
Number of subjects: 80

Group type: COMPARATOR
Intervention: clofibrate
Number of subjects: 80
Study: 31443919

Group type: EXPERIMENTAL
Intervention: modified Valsalva maneuver (mVM)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: standard Valsalva maneuver (sVM)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: carotid sinus massage (CSM)
Number of subjects: 98
Study: 27914730

Group type: EXPERIMENTAL
Intervention: 3-dimensional monitor
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2-dimensional monitor
Number of subjects: 20
Study: 25629571

Group type: EXPERIMENTAL
Intervention: Continuous Entonox use
Number of subjects: 100

Group type: COMPARATOR
Intervention: As-required Entonox use
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Patients with high anxiety
Number of subjects: 100
Study: 23614401

Group type: EXPERIMENTAL
Intervention: Potentiated ZPT formula
Number of subjects: 620

Group type: COMPARATOR
Intervention: Dual Active shampoo
Number of subjects: 620
Study: 21862679

Group type: EXPERIMENTAL
Intervention: Aphasia group
Number of subjects: 7

Group type: COMPARATOR
Intervention: Age-matched control group (N=9)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Younger control group (N=10)
Number of subjects: 7
Study: 19550340

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 1 microg/kg for 10 min followed by infusion of 0.2-0.7 microg/kg/h)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Midazolam (bolus dose 0.04 mg/kg followed by infusion of 0.04-0.08 mg/kg/h)
Number of subjects: 61
Study: 16537075

Group type: EXPERIMENTAL
Intervention: Identifiable icons
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medium icons
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vague icons
Number of subjects: 0
Study: 15491379

Group type: EXPERIMENTAL
Intervention: Catch-up growth group (22 children)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Children with PEM who did not show catch-up growth (8 children)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified how many)
Number of subjects: 30
Study: 11686450

Group type: EXPERIMENTAL
Intervention: 350‐centistroke polydimethicone (n = 16)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sterile saline (n = 15)
Number of subjects: 31
Study: 9692106

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation after combined beta- and atropinic blockade in mild asthmatics
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation in nocturnal asthmatics after atropinic blockade alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Capsaicin inhalation in normal subjects after atropine plus propranolol
Number of subjects: 24
Study: 7869682

Group type: EXPERIMENTAL
Intervention: Combined superior oblique tendon tuck of 5 or 6 mm with transposition of the new insertion to the posterior margin of the original insertion and recession of the inferior oblique muscle of 5 or 6 mm with anterior displacement of 4‐6 mm (Group A)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Conventional superior oblique tendon tuck of 5 or 6 mm combined with recession of the inferior oblique muscle (Group B)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Conventional superior oblique tendon tuck of 6 mm combined with posterior tenotomy of the inferior oblique muscle (Group C)
Number of subjects: 38
Study: 3653590

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg tid
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30138085

Group type: EXPERIMENTAL
Intervention: C-MTX (COG-augmented BFM regimen)
Number of subjects: 1895

Group type: COMPARATOR
Intervention: HDMTX (Berlin-Frankfurt-Muenster high-dose intravenous MTX regimen)
Number of subjects: 1895
Study: 28456330

Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 26263075

Group type: EXPERIMENTAL
Intervention: Ramosetron 0.3 mg (group R)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Ondansetron 4 mg (group O4)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Ondansetron 8 mg (group O8)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: All groups (R, O4, O8)
Number of subjects: 117
Study: 24024826

Group type: EXPERIMENTAL
Intervention: Stepped care intervention including self-help material, chat forum, FAQ section, and cognitive behavioral therapy (CBT) administered by a personal therapist if symptoms persist.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 0
Study: 21908956

Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy (performed in 213 patients)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Control group (no pericardial incision performed in 212 patients)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Posterior pericardiotomy
Number of subjects: 425
Study: 19159941

Group type: EXPERIMENTAL
Intervention: Post-tonsillectomy injection of bupivacaine
Number of subjects: 180

Group type: COMPARATOR
Intervention: Pre-incisional infiltration technique
Number of subjects: 180

Group type: COMPARATOR
Intervention: Post-tonsillectomy packing with 0.5% bupivacaine-soaked gauze swab
Number of subjects: 180
Study: 17565235

Group type: EXPERIMENTAL
Intervention: Melagatran/Ximelagatran
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 0
Study: 14739050

Group type: EXPERIMENTAL
Intervention: Reduced fat (RF) diet
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual diet (control, CD)
Number of subjects: 136
Study: 10669363

Group type: EXPERIMENTAL
Intervention: Trivalent live attenuated influenza vaccine (LAIV)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 9107443

Group type: COMPARATOR
Intervention: Verapamil SR monotherapy 120 mg
Number of subjects: 746

Group type: COMPARATOR
Intervention: Verapamil SR monotherapy 180 mg
Number of subjects: 746

Group type: COMPARATOR
Intervention: Verapamil SR monotherapy 240 mg
Number of subjects: 746

Group type: COMPARATOR
Intervention: Trandolapril monotherapy 0.5 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Trandolapril monotherapy 2 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Trandolapril monotherapy 8 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Combination therapy 0.5/120 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Combination therapy 0.5/180 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Combination therapy 2/180 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Combination therapy 2/240 mg
Number of subjects: 746

Group type: EXPERIMENTAL
Intervention: Combination therapy 8/240 mg
Number of subjects: 746

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 746
Study: 1315560

Group type: EXPERIMENTAL
Intervention: Renin inhibitor CGP 38560A (125 micrograms kg‐1)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Renin inhibitor CGP 38560A (250 micrograms kg‐1)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 5% glucose (control)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: ACE inhibitor lisinopril (20 mg)
Number of subjects: 6
Study: 3964713

Group type: EXPERIMENTAL
Intervention: Urokinase
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 117